Other Species / Isoforms
  ERP29 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
T43-p
KGALPLDtVTFykVI
0 1
ERP29 (human) KGALPLDtVTFykVI T43-p
ERP29 (mouse) KGALPLDTVTFYKVI T45
ERP29 (rat) KGALPLDTVTFYKVI T43
Y47-p
PLDtVTFykVIPKSk
0 1
ERP29 (human) PLDtVTFykVIPKSk Y47-p
ERP29 (mouse) PLDTVTFYKVIPKSK Y49
ERP29 (rat) PLDTVTFYKVIPKSk Y47
K48-ub
LDtVTFykVIPKSkF
0 2
ERP29 (human) LDtVTFykVIPKSkF K48-ub
ERP29 (mouse) LDTVTFYKVIPKSKF K50
ERP29 (rat) LDTVTFYKVIPKSkF K48
K54-ac
ykVIPKSkFVLVKFD
0 3
ERP29 (human) ykVIPKSkFVLVKFD K54-ac
ERP29 (mouse) YKVIPKSKFVLVKFD K56
ERP29 (rat) YKVIPKSkFVLVKFD K54-ac
Y64-p
LVKFDTQyPyGEkQD
1 15
ERP29 (human) LVKFDTQyPyGEkQD Y64-p
ERP29 (mouse) LVKFDTQYPyGEKQD Y66
ERP29 (rat) LVKFDTQYPyGEkQD Y64
Y66-p
KFDTQyPyGEkQDEF
Upstream
1 371
Treatment
  • imatinib
ERP29 (human) KFDTQyPyGEkQDEF Y66-p
ERP29 (mouse) KFDTQYPyGEKQDEF Y68-p
ERP29 (rat) KFDTQYPyGEkQDEF Y66-p
K69
TQyPyGEKQDEFKRL
0 1
ERP29 (human) TQyPyGEKQDEFKRL K69
ERP29 (mouse) TQYPyGEKQDEFKRL K71
ERP29 (rat) TQYPyGEkQDEFKRL K69-ac
K69-ub
TQyPyGEkQDEFKRL
0 1
ERP29 (human) TQyPyGEkQDEFKRL K69-ub
ERP29 (mouse) TQYPyGEKQDEFKRL K71
ERP29 (rat) TQYPyGEKQDEFKRL K69
S80-p
FKRLAENsASsDDLL
0 1
ERP29 (human) FKRLAENsASsDDLL S80-p
ERP29 (mouse) FKRLAENSASSEELL S82
ERP29 (rat) FKRLAENSASSDDLL S80
S83-p
LAENsASsDDLLVAE
0 1
ERP29 (human) LAENsASsDDLLVAE S83-p
ERP29 (mouse) LAENSASSEELLVAE S85
ERP29 (rat) LAENSASSDDLLVAE S83
Y119-p
KESYPVFyLFrDGDF
0 1
ERP29 (human) KESYPVFyLFrDGDF Y119-p
ERP29 (mouse) KESYPVFYLFRDGDL Y121
ERP29 (rat) KESYPVFYLFRDGDF Y119
R122-m1
YPVFyLFrDGDFENP
0 1
ERP29 (human) YPVFyLFrDGDFENP R122-m1
ERP29 (mouse) YPVFYLFRDGDLENP R124
ERP29 (rat) YPVFYLFRDGDFENP R122
T133-p
FENPVPYtGAVkVGA
0 1
ERP29 (human) FENPVPYtGAVkVGA T133-p
ERP29 (mouse) LENPVLYNGAVKVGA N135
ERP29 (rat) FENPVPYSGAVKVGA S133
K137-ub
VPYtGAVkVGAIQRW
0 1
ERP29 (human) VPYtGAVkVGAIQRW K137-ub
ERP29 (mouse) VLYNGAVKVGAIQRW K139
ERP29 (rat) VPYSGAVKVGAIQRW K137
K182-ub
EARQALLkQGQDNLS
Upstream
0 4
Treatment
  • MG132
ERP29 (human) EARQALLkQGQDNLS K182-ub
ERP29 (mouse) EARQAILKQGQDGLL K184
ERP29 (rat) EARQAILKQGQDGLS K182
K192-ub
QDNLSSVkETQKKWA
0 1
ERP29 (human) QDNLSSVkETQKKWA K192-ub
ERP29 (mouse) QDGLLSVKETEKKWA K194
ERP29 (rat) QDGLSGVKETDKKWA K192
K192-sc
QDNLSSVkETQKKWA
0 1
ERP29 (human) QDNLSSVkETQKKWA K192-sc
ERP29 (mouse) QDGLLSVKETEKKWA K194
ERP29 (rat) QDGLSGVKETDKKWA K192
K204
KWAEQYLKIMGKILD
0 1
ERP29 (human) KWAEQYLKIMGKILD K204
ERP29 (mouse) KWASQYLKIMGKILD K206
ERP29 (rat) KWASQYLkIMGKILD K204-ac
T222-p
DFPASEMtRIARLIE
0 1
ERP29 (human) DFPASEMtRIARLIE T222-p
ERP29 (mouse) DFPASEMARIGKLIE A224
ERP29 (rat) DFPASELARISkLIE A222
R226
SEMtRIARLIEKNKM
0 1
ERP29 (human) SEMtRIARLIEKNKM R226
ERP29 (mouse) SEMARIGKLIENKMS K228
ERP29 (rat) SELARISkLIENKMS K226-ac
K243-ub
GKKEELQksLNILtA
0 1
ERP29 (human) GKKEELQksLNILtA K243-ub
ERP29 (mouse) SKKEELQKSLNILTA K244
ERP29 (rat) GKKEELQRSLNILTA R242
S244-p
KKEELQksLNILtAF
0 1
ERP29 (human) KKEELQksLNILtAF S244-p
ERP29 (mouse) KKEELQKSLNILTAF S245
ERP29 (rat) KKEELQRSLNILTAF S243
T249-p
QksLNILtAFQKKGA
0 1
ERP29 (human) QksLNILtAFQKKGA T249-p
ERP29 (mouse) QKSLNILTAFRKKEA T250
ERP29 (rat) QRSLNILTAFRKKGA T248